Internal Server Error

Algorithmic Biologics - About the company

Algorithmic Biologics is a seed company based in Bengaluru (India), founded in 2021 by Manoj Gopalkrishnan. It operates as a Provider of software solutions for molecular diagnostics and discovery. Algorithmic Biologics has raised $2.84M in funding from Axilor Ventures and Bharat Innovation Fund, with a current valuation of $*****. The company has 95 active competitors, including 21 funded and 7 that have exited. Its top competitors include companies like Metaphore, Panakeia and Tahoe Bio.

Company Details

Provider of software solutions for molecular diagnostics and discovery. The company offers Tapestry that integrates with standard molecular testing workflows, enabling the execution of computing applications that enhance molecular testing.
Social
X
Email ID
*****@algorithmicbiologics.com
Phone Number
+91 **********
Registered Address
#363, 3rd Block, Koramangala, Koramangala, Bangalore, Bangalore South, Karnataka, India, 560034
Key Metrics
Founded Year
2021
Location
Bengaluru, India
Stage
Seed
Total Funding
$2.84M in 3 rounds
Latest Funding Round
Post Money Valuation
$***** as on Nov 23, 2023
Ranked
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
19 as on Jun 30, 2026
Similar Companies
Sign up to download Algorithmic Biologics' company profile

Algorithmic Biologics's funding and investors

Algorithmic Biologics has raised a total funding of $2.84M over 3 rounds. Its first funding round was on Jul 13, 2021. Its latest funding round was a Seed round on Nov 23, 2023 for $*****. 2 investors participated in its latest round. Algorithmic Biologics has 4 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Algorithmic Biologics:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 23, 2023
5946017
Seed
2417850
8309072
2394120
4500482
Jan 12, 2022
8368582
Seed
4599353
3594731
7753358
Jul 13, 2021
7945947
Seed
1847098
2205084
3805149
lockAccess funding benchmarks and valuations. Sign up today!

Algorithmic Biologics' founders and board of directors

Founder? Claim Profile
The founders of Algorithmic Biologics is Manoj Gopalkrishnan. Manoj Gopalkrishnan is the CEO of Algorithmic Biologics.
Here are the details of Algorithmic Biologics' key team members:

Algorithmic Biologics' Board of Directors

Algorithmic Biologics's board has 1 active member. Manoj Gopalkrishnan is part of team.
Here is the list of Algorithmic Biologics' board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
5y 5m

Algorithmic Biologics' employee count trend

Algorithmic Biologics has 19 employees as of Jun 26. Here is Algorithmic Biologics's employee count trend over the years:
Employee count trend for Algorithmic Biologics
lockUncover Algorithmic Biologics' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Algorithmic Biologics's Competitors and alternates

Top competitors of Algorithmic Biologics include Metaphore, Panakeia and Tahoe Bio. Here is the list of Top 10 competitors of Algorithmic Biologics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Metaphore
Metaphore
2021, Cambridge (United States), Series C
Provider of machine language and computational platform for drug discovery
$50M
59/100
2nd
Logo for Panakeia
Panakeia
2018, London (United Kingdom), Seed
Provider of AI-based software for diagnosis and precision treatment
$3.79M
56/100
3rd
Logo for Tahoe Bio
Tahoe Bio
2022, San Francisco (United States), Series B
Developer of AI models for drug design using single-cell maps.
$30M
51/100
4th
Logo for Algorithmic Biologics
Algorithmic Biologics
2021, Bengaluru (India), Seed
Provider of software solutions for molecular diagnostics and discovery
$2.84M
47/100
5th
Logo for PharmaTher
PharmaTher
2020, Toronto (Canada), Public
Provider of AI-based platform for repurposing psychedelic drugs
-
-
47/100
6th
Logo for Molecular Quantum Solutions
Molecular Quantum Solutions
2019, Copenhagen (Denmark), Seed
Provider of computational tools for research and development
$654K
46/100
7th
Logo for Evolved By Nature
Evolved By Nature
2013, Medford (United States), Series C
Developer of bioactive peptides derived from silk protein for skincare
$211M
44/100
8th
Logo for Physiomics
Physiomics
2001, Oxford (United Kingdom), Public
Provider of virtual tumour technology based solutions for pre-clinical and clinical development
-
43/100
9th
Logo for Paradigm4
Paradigm4
2009, Waltham (United States), Series A
Clinical data management and analytic tools
-
41/100
10th
Logo for StoneWise
StoneWise
2018, Haidian (China), Series B
Provider of a software solution solution for molecular modeling
$100M
41/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Algorithmic Biologics's competitors? Click here to see the top ones

Algorithmic Biologics's Latest cap tables and shareholding

Founders (largest shareholder) own 45.93%, Funds own 43.46%, Other People own 0.01% and ESOP Pool own 10.60%. The net worth of Algorithmic Biologics's founders is INR 41.8Cr as of Nov 23, 2023.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
45.93%
41.8Cr
9415420
4266994
1720237
1496073
7464889
1618291
4368026
4762562
9177539
9872794
Fund
43.46%
39.6Cr
9764527
8729962
1175572
9063970
2167520
6284170
8771834
3503385
9446628
7493826
1050
7700
1310
2038
8824
6420
Other People
0.01%
50.1K
0
0
0
0
ESOP Pool
10.60%
9.65Cr
3428281
1128624
8721144
3197120
Total
100.00%
91.1Cr
6978104
2478699
7103062
7673216
lockTo unlock detailed Cap Table of Algorithmic Biologics Sign up today!
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer

Algorithmic Biologics's Investments and acquisitions

Algorithmic Biologics has made no investments or acquisitions yet.

Reports related to Algorithmic Biologics

Here is the latest report on Algorithmic Biologics's sector:

News related to Algorithmic Biologics

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Algorithmic Biologics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford